Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and -negative clinical isolates of Staphylococcus epidermidis

Antimicrob Agents Chemother. 2010 Jun;54(6):2707-11. doi: 10.1128/AAC.01565-09. Epub 2010 Mar 15.

Abstract

Biofilm formation in Staphylococcus epidermidis is mediated by icaADBC-dependent and -independent pathways. Subinhibitory concentrations of erythromycin, azithromycin, and clarithromycin enhanced, in a dose-dependent manner, the level of biofilm formation by 20% (21/105 isolates) by macrolide-resistant ica-positive and -negative isolates tested in vitro. The presence of ica, however, apparently produced an enhanced effect on biofilm formation. The levels of expression of the biofilm-related genes icaA, atlE, fruA, pyrR, sarA, and sigB were increased in response to erythromycin. The results likely underscore the potential clinical relevance of macrolide-induced biofilm growth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Base Sequence
  • Biofilms / drug effects*
  • Biofilms / growth & development*
  • DNA Primers / genetics
  • Dose-Response Relationship, Drug
  • Erythromycin / administration & dosage
  • Gene Expression / drug effects
  • Genes, Bacterial*
  • Humans
  • In Vitro Techniques
  • Macrolides / administration & dosage*
  • Microscopy, Electron, Scanning
  • Reverse Transcriptase Polymerase Chain Reaction
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology*
  • Staphylococcus epidermidis / drug effects*
  • Staphylococcus epidermidis / genetics*
  • Staphylococcus epidermidis / isolation & purification
  • Staphylococcus epidermidis / physiology

Substances

  • Anti-Bacterial Agents
  • DNA Primers
  • Macrolides
  • Erythromycin